Drug Master Files for: CEFPROZIL
✉ Email this page to a colleague
CEFPROZIL Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
16973 | I | II | 11/21/2003 | SUN PHARMACEUTICAL INDUSTRIES LTD | CEFPROZIL USP (NON-STERILE BULK) |
17375 | A | II | 5/13/2004 | ORCHID PHARMA LTD | CEFPROZIL |
17453 | I | II | 6/7/2004 | SANDOZ PRIVATE LTD | CEFPROZIL |
17731 | A | II | 9/29/2004 | LUPIN LTD | CEFPROZIL USP |
17827 | A | II | 11/16/2004 | TEVA PHARMACEUTICAL INDUSTRIES LTD | CEFPROZIL |
18434 | I | II | 6/16/2005 | HETERO DRUGS LTD | CEFPROZIL MONOHYDRATE |
18469 | A | II | 6/28/2005 | AUROBINDO PHARMA LTD | CEFPROZIL USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information